Discover how intestinal microbiota influence doxorubicin responsiveness in triple-negative breast cancer and the future of microbiome-based cancer therapy.
Explore the groundbreaking research linking gut microbiota dysbiosis to breast cancer risk, mechanisms, and potential interventions.
Exploring the therapeutic potential of probiotics in breast cancer treatment through immune modulation and gut microbiome regulation.
Discover how gut microbiome signatures predict survival outcomes in breast cancer patients receiving eribulin immunotherapy. Explore the fascinating science behind microbial influence on cancer treatment.
Exploring the revolutionary connection between gut microbiome and breast cancer development, risk factors, and innovative treatment approaches.